Markus Boehm

Characterization of the Novel and Specific PI3Kα Inhibitor NVP-BYL719 and Development of the Patient Stratification Strategy for Clinical Trials

Christine Fritsch, Alan Huang, Christian Chatenay‐Rivauday et al. · Molecular Cancer Therapeutics · 2014 · 462 citations

Pten Mutation, Somatic Pik3ca Mutations, Pharmacotherapy +18

Adaptins

Markus Boehm, Juan S. Bonifacino · Molecular Biology of the Cell · 2001 · 422 citations

Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases <i>In vitro</i> and <i>In vivo</i>

Wilko Weichert, A.-E. Roske, Silvia Niesporek et al. · Clinical Cancer Research · 2008 · 370 citations

Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 γ–σ1 and AP-3 δ–σ3 hemicomplexes

Katy Janvier, Yukio Kato, Markus Boehm et al. · The Journal of Cell Biology · 2003 · 236 citations · Full text

Immunology, Molecular Biology, Transmembrane Proteins +22

High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis

W Weichert, Markus Boehm, Volker Gekeler et al. · British Journal of Cancer · 2007 · 141 citations · Full text